von Willebrand factor, endothelial dysfunction, and cardiovascular disease
- 1 June 2006
- journal article
- review article
- Published by Elsevier BV in Journal of Thrombosis and Haemostasis
- Vol. 4 (6), 1186-1193
- https://doi.org/10.1111/j.1538-7836.2006.01949.x
Abstract
No abstract availableThis publication has 77 references indexed in Scilit:
- The regulation of endothelial VWF secretion by nitric oxide: is it physiological?Journal of Thrombosis and Haemostasis, 2006
- Cysteine-mutations in von Willebrand factor associated with increased clearanceJournal of Thrombosis and Haemostasis, 2005
- Plasma von Willebrand factor and arterial agingJournal of Thrombosis and Haemostasis, 2005
- Patients With Type 3 Severe von Willebrand Disease Are Not Protected Against AtherosclerosisCirculation, 2004
- A Critical Role of Platelet Adhesion in the Initiation of Atherosclerotic Lesion FormationThe Journal of Experimental Medicine, 2002
- β-2 Adrenergic Receptor Variants Affect Resting Blood Pressure and Agonist-Induced Vasodilation in Young Adult CaucasiansHypertension, 1999
- ALTERED LEVELS OF SOLUBLE ADHESION MOLECULES IN RHEUMATOID ARTHRITIS, VASCULITIS AND SYSTEMIC SCLEROSISRheumatology, 1995
- Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.JCI Insight, 1995
- Calcium/calmodulin transduces thrombin-stimulated secretion: studies in intact and minimally permeabilized human umbilical vein endothelial cells.The Journal of cell biology, 1992
- Inducible secretion of large, biologically potent von Willebrand factor multimersCell, 1986